Home Page

Chairman's Letter
Committees
Opening Lectures
International Society of Heart
Failure Awards

Thanks

General Information
Social Program
List of Exhibitors
Scientific Program
Satellite Symposium
Monday, July 10, 2000
Registration Form
Accommodation
Form (Word Document)
Back to CARDIOLOGY ONLINE

SCIENTIFIC PROGRAM

MONDAY,
JULY 10, 2000

TUESDAY, 
JULY 11, 2000

WEDNESDAY,
JULY 12, 2000

 

TUESDAY, JULY 11, 2000
08:30-10:45   HALL A
PL06:  Plenary Session:
CARDIOMYOPATHIES: HYPERTROPHIC AND DILATED
Chairpersons: U. Elkayam, Los Angeles CA, USA
E.D. Wigle, Toronto Ontario, Canada
 
    Abstract Page
08:30  MECHANISMS & MANAGEMENT OF CONGESTIVE HEART FAILURE IN HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
E.D. Wigle, Toronto ON, Canada
 54
08:45  TRANSCORONARY ABLATION OF SEPTUM HYPERTROPHY (TASH) FOR HOCM: AN ALTERNATIVE TO OPERATION AND PACEMAKER THERAPY (Invited Lecture)
H.J. Kuhn, F. Gietzen, C. Leuner, L. Obergassel, F. Lieder, C. Strunck-Mueller, Bielefeld, Germany 
54
09:00  CURRENT SURGICAL MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
H.V. Schaff, Rochester MN, USA
 55
09:15  PERIPARTUM CARDIOMYOPATHY (Invited Lecture)
U. Elkayam, Los Angeles CA, USA 
55
09:30  OBESITY CARDIOMYOPATHY (Invited Lecture)
M.A. Alpert, Mobile AL, USA
 55
09:45  OXIDATIVE STRESS IN THE PATHOPHYSIOLOGY OF ADRIAMYCIN-INDUCED CONGESTIVE HEART FAILURE (Invited Lecture)
P.K. Singal, Winnipeg MB, Canada 
55
10:00  SPECIFIC INFILTRATIVE CARDIOMYOPATHY CONCOMITANT WITH PERICARDIAL EFFUSION IN PATIENTS WITH B-THALASSEMIA (Invited Lecture)
A. Hourzamanis, N.J. Angomachalelis, R. Zacharski, M. Angelski, T. Mesimeris, E. Serasli, Thessaloniki, Greece 
56
10:15  VIRAL MYOCARDITIS AND DILATED CARDIOMYOPATHY (Invited Lecture)
N. Kipshidze, Tbilisi, Georgia 
56
10:30  FUNCTIONAL ABNORMALITIES OF GAP JUNCTIONS IN CARDIOMYOPATHIC SYRIAN HAMSTERS: A ROLE OF TYROSINE PHOSPHORYLATION OF CONNEXIN-43 (Invited Lecture)
M. Hori, Osaka, Japan 
56
10:45  Coffee Break  
TUESDAY, JULY 11, 2000
08:30-11:00   HALL B
S58: 

Session:
VASCULAR ENDOTHELIAL FUNCTION, INFLAMMATORY MEDIATORS, CYTOKINES, NITRIC OXIDE, PHARMACOLOGIC MODULATION
Chairpersons: A. Lerman, Rochester MN, USA 
M.A. Rossi, Ribeirao Preto S.P., Brazil

 
    Abstract Page
08:30  ENDOTHELIAL FUNCTION FROM BENCH TO BEDSIDE (Invited Lecture)
A. Lerman, Rochester MN, USA
 56
08:45  CIRCULATING IMMUNOINFLAMMATORY GRADIENT IN PATIENTS WITH ADVANCED HEART FAILURE
G.B. Grossman, C.P. Campos, L.E. Rohde, N. Clausell, Porto Alegre, Brazil 
57
09:00  ENDOTOXIN DEPRESSES MYOCARDIAL CONTRACTILITY OF ISOLATED RAT HEARTS VIA TNF-a SYNTHESIS: EVIDENCE FOR A ROLE OF SPHINGOSINE AND CYCLOOXYGENASE-2-DERIVED THROMBOXANE PRODUCTION
U. Grandel, U. Sibelius, A. Blum, L. Fink, M. Buerke, M. Rainer, M. Bohle, W. Seeger, F. Grimminger, Giessen, Mainz, Germany
 57
09:15  CHANGES IN THE PRODUCTION OF INFLAMMATORY RELATED CYTOKINES BY STATINS
A. Rezaie-Majd, J. Wojta, H.G. Kress, T. Maca, E. Minar, M. Baghestanian, Vienna, Austria 
57
09:30  CARDIAC NITRIC OXIDE IS INCREASED IN PATIENTS WITH CHRONIC HEART
F. Masashi, N. Shinsuke, O. Tomoki, M. Takakazu, K. Junichi, W. Tetsuya, I. Nobuaki, N. Mayu, Y. Hideyuki, I. Akio, N. Seiki, K. Masafumi, N. Koichi, H. Masatsugu, Amagasaki, Suita, Japan 
57
09:45  IMPROVEMENT IN ENDOTHELIUM-DEPENDENT FUNCTION IN PATIENTS WITH CLASS II & III ANGINA BY A MEDICAL FOOD
A.J. Maxwell, M.P. Zapien, B. Anderson, P.H. Stone, Boston MA, USA 
58
10:00  CARNITINES INHIBITS OXYGEN FREE RADICAL RELEASE BY ENDOTHELIAL CELL AND LEUKOCYTES
E. Rossi, C. Caroselli, L. Loffredo, A. Picca, S. Natoli, F. Violi, Rome, Italy 
58
10:15  EFFECTS OF ACUTE ESTROGEN ADMINISTRATION ON THE CARDIAC PERFORMANCE OF PATIENTS WITH CHRONIC HEART FAILURE
D. Leftheriotis, S. Adamopoulos, E. Sbarouni, G. Karavolias, D.T. Kremastinos, Athens, Greece 
58
10:30 

EFFECTS OF ATORVASTATIN ON FIBRINOLYTIC SYSTEM IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
L. Pucci, S. Bandinelli, D. Lucchesi, F. Caricato, R. Navalesi, A. Bertolotto, G. Penno, Pisa, Italy 

58
10:45  MICROVESSEL WALL PERMEABILITY IMPROVES IN PRIMARY HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH ATORVASTATIN
S. Bandinelli, A. Bertolotto, L. Pucci, R. Navalesi, G. Penno, Pisa, Italy
 59
11:00  Coffee Break  
TUESDAY, JULY 11, 2000
08:30-10:15    HALL D
S60: 

Session:
EXERCISE PHYSIOLOGY AND REHABILITATION IN HEART FAILURE
Chairpersons: O. Abdel-Aziz, Cairo, Egypt Abstract Page
M. Shechter, Tel Hashomer, Israel

 
    Abstract Page
08:30  DOES BETA BLOCKADE THERAPY MODIFY EXERCISE INTENSITY PRESCRIPTION IN CONGESTIVE HEART FAILURE?
D. Curnier, M. Galinier, A. Pathak, J. Fourcade, M. Bousquet, J.-M. Fauvel, J.-M. Senard, J.P. Bounhoure, J.-L. Montastruc, Toulouse, St. Orens, France
 59
08:45  VENTILATORY AND PERIPHERAL COMPONENTS OF IMPROVED VO2MAX IN PATIENTS WITH HEART FAILURE
T.R. McConnell, J.S. Mandak, J.S. Sykes, H. Fesniak, H. Dasgupta, Danville PA, USA 
59
09:00  VARIOUS REHABILITATION PROGRAMS IN CONGESTIVE HEART FAILURE
B. Bacior, A. Kubinyi, W.M. Szot, A. Klecha, J. Skula, K. Kawecka-Jaszcz, Krakow, Poland 
59
09:15  THE EFFECTS OF A SELF MONITORED PHYSICAL TRAINING PROGRAM ON EXERCISE PERFORMANCE AND ON SYMPATHETIC ACTIVITY IN PATIENTS WITH HEART FAILURE
R.B. Herman, S.A. Behzad, A. Doci, I.K.S. Chua, V.T. Johgalingam, A.M. Mustafa, I.R. Husain, A.M. Choy, C.C. Lang, Andalas, Indonesia, Kuala Lumpur, Malaysia
 60
09:30  DIFFERENCES IN CARDIOPULMONARY INDICES BETWEEN PATIENTS WITH LV DYSFUNCTION WITH NO ISCHEMIA AND PATIENTS WITH SIGNIFICANT ISCHEMIA AND GOOD LV FUNCTION DURING EXERCISE
E. Klainman, J. Lebzelter, G. Fink, N. Zafrir, M.R. Kramer, Givataim, Petah Tiqva, Israel
 60
09:45  CHANGES IN QUALITY OF LIFE IN MEN WITH HEART FAILURE DURING REGULAR PHYSICAL TRAINING
A. Kubinyi, M. Klocek, B. Bacior, W.M. Szot, K. Kawecka-Jaszcz, Krakow, Poland
 60
10:00 

EFFECTS OF LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC FUNCTION ON EXERCISE CAPACITY IN PATIENTS WITH SURVIVORS OF ANTERIOR MYOCARDIAL INFARCTION
M. Kabukcu, E. Yanik, F. Demircioglu, A. Belgi, O. Sancaktar, F. Ersel, Antalya, Turkey 

60
10:15  Coffee Break  
TUESDAY, JULY 11, 2000
11:00-13:00   HALL A
PL07:  Plenary Session:
MYOCARDIAL REVASCULARIZATION: NEWER INTERVENTIONAL TECHNIQUES
W. Ganz, Los Angeles CA, USA
H.J. Kuhn, Bielefeld, Germany
 
    Abstract Page
11:00  THROMBOLYSIS: VIEW FROM THE BENCH AND THE BEDSIDE (Invited Lecture)
W. Ganz, Los Angeles CA, USA
 61
 11:15

 HOW DO WE AVOID LOSING MYOCARDIAL CELLS DURING PERCUTANEOUS INTERVENTION IN CORONARY SYNDROMES? (Invited Lecture)
P.C. Block, Portland OR, USA

 61
11:30  CARDIAC GENE THERAPY: PROMISES FOR THE NEW CENTURY (Invited Lecture)
T.K. Rosengart, New York NY, USA
 61
11:45  BEYOND MORPHOLOGY: NEW CORONARY PHYSIOLOGIC APPROACHES TO INTERVENTIONS (Invited Lecture)
V. Klauss, Munich, Germany 
62
12:00  THE ROLE OF ULTRASOUND IN CORONARY STENTING (Invited Lecture)
H. Mudra, A. Knape, C. Spes, Munich, Germany 
62
12:15  ANGIOPLASTY OF INFARCT RELATED ARTERY IN AMI: EFFICIENT OR EFFECTIVE (IMPRESSIVE) ONLY? (Invited Lecture)
D.G. Iosseliani, Moscow, Russia
 62
12:30  INTRAVASCULAR BRACHYTHERAPY WITH RHENIUM-188 BALLOON: RADIANT PILOT STUDY (Invited Lecture)
R.R. Makkar, J. Whiting, A. Li, J. Hausleiter, A. Robinson, N. Eigler, Los Angeles, CA, USA 
62
12:45  EARLY STENTING AFTER THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION - FIRST RESULTS OF A RANDOMIZED STUDY
B. Hennen, B. Scheller, B. Hammer, J. Hofer, Homburg/Saar, Germany 
63
13:00  Lunch Break  
TUESDAY, JULY 11, 2000
11:00-12:45    HALL B
S61:  Session:
MOLECULAR BIOLOGY: GENETIC STUDIES, APOPTOSIS
Chairpersons: N.S. Dhalla, Winnipeg Manitoba, Canada
W.J. Koch, Durham NC, USA
 
     Abstract Page
11:00  DIFFERENTIAL GENE EXPRESSION OF ANP AND ADRENOMEDULLIN IN ISOPROTERENOL INDUCED CARDIAC HYPERTROPHY IN RATS
M. Toth, Z. Lako-Futo, G. Foldes, I. Szokodi, H. Ruskoaho, Z. Bori, R. deChatel, Budapest, Hungary 
63
11:15  A NEW HIGH RESOLUTION ECG RECORDING TECHNIQUE FOR EVALUATION OF CARDIAC CONDUCTION AND REFRACTORINESS IN ISOLATED PERFUSED MICE HEARTS
A. Lueger, G. Stark, M. Brodmann, D. Scherr, R. Gasser, H. Tritthart, Graz, Austria
 63
11:30  DNA FRAGMENTATION FACTOR DFF45/ICAD IS UPREGULATED IN CARDIOMYOCYTES ISOLATED FROM EXPLANTED FAILED HUMAN HEARTS
A. Todor, V.G. Sharov, R.C. Gupta, S. Mishra, N. Silverman, S. Goldstein, H.N. Sabbah, Detroit MI, USA 
63
11:45  POSTISCHEMIC APOPTOSIS AND FUNCTIONAL RECOVERY AFTER ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKADE IN THE ISOLATED WORKING RAT HEART
S. Musat-Marcu, R. Moudgil, B.I. Jugdutt, Edmonton AB, Canada
 64
12:00  INTERLEUKIN-6/SOLUBLE INTERLEUKIN-6 RECEPTOR COMPLEX INHIBITS MYOCARDIAL APOPTOSIS
K. Matsushita, S. Iwanaga, T. Oda, K. Kimura, M. Shimada, M. Tanaka, S. Matsumura, S. Ogawa, Tokyo, Japan
 64
12:15  DOES ENTEROVIRUS INFECTION PROTECT MYOCARDIUM FROM APOPTOSIS?
P. Alter, E. Meyer, M. Jobmann, B. Maisch, Marburg/Lahn, Germany 
64
12:30  THE ROLE OF HOST IMMUNOGENETIC FACTORS IN THE SUSCEPTIBILITY AND PATHOGENESIS OR RHEUMATIC HEART DISEASE
M. Kotb, Y. Guedez, M. El-Demellawy, Memphis TN, USA 
64
12:45  Lunch Break  
TUESDAY, JULY 11, 2000
11:00-13:00    HALL C
S59:  Session:
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME
Chairpersons: P.C. Deedwania, Fresno CA, USA 
R.E. Hobbs, Cleveland OH, USA
 
    Abstract Page
11:00  EFFECT OF CAPTOPRIL VS LOSARTAN ON PLASMA BIG ENDOTHELIN IN CHRONIC HEART FAILURE (NEUROHUMORAL SUBSTUDY ELITE ID
R. Pacher, B. Stanek, C. Benedict, Vienna, Austria, Houston TX, USA
 65
11:15  IMPACT OF BUNDLE BRANCH BLOCK (BBB) PATTERN ON EKG ON SURVIVAL IN PATIENTS WITH CONGESTIVE HEART FAILURE (CHF). AN EIGHT YEAR FOLLOW UP STUDY
S.A. Hassan, D. Nori, S. Bhatt, S. Borzak, A. Philbin, W.D. Weaver, S. Soman, S. Shah, P.A. McCullough, Detroit MI, USA 
65
11:30  TRIIODOTHYRONINE EFFECTS ON HUMAN CARDIOMYOCYTE PHENOTYPE AND INTRACELLULAR CALCIUM HOMEOSTASIS
F. Forini, T. Pizzorusso, G.M. Ratto, V. Vanini, G. Iervasi, Pisa, Massa, Italy 
65
11:45  SENSITIVITY AND SPECIFICITY OF QRS DURATION TO PREDICT ACUTE BENEFIT IN HEART FAILURE PATIENTS WITH VENTRICULAR RESYNCHRONIZATION
V. Kadhiresan, J. Vogt, A. Auricchio, C. Butter, C. Stellbrink, J. Spinelli, J. Ding, L. Liu, A. Doegler, Bad Oyenhausen, Germany, St. Paul MN, USA 
65
12:00  HEART RATE VARIABILITY IN CONGESTIVE HEART FAILURE: DOES ITS DECREASE CORRELATE TO HEMODYNAMIC PARAMETERS AT REST AND DURING EXERCISE?
F. Edelmann, C. Weinbrenner, M. Knapp, G. Simonis, R.H. Strasser, Heidelberg, Germany 
66
12:15  CARDIAC OUTCOMES WITH OUTPATIENT INOTROPIC INFUSIONS IN PATIENTS WITH SEVERE HEART FAILURE
K. Vijayaraghavan, S. Crumm, Q. Helgeson, Phoenix AZ, USA 
66
12:30  THE T, THE I, OR BOTH OF THEM: A NOVEL MULTI-MARKER APPROACH IN CONGESTIVE HEART FAILURE
E.D. Missov, D.M. Lau, T. De Marco, San Francisco CA, USA
 66
12:45  AUTONOMIC MODULATION IN SEVERE HEART FAILURE
A.F. Folino, V. Kitenge, A. Porta, S. Cerutti, B. Tokajuk, S. Dalla Volta, Padua, Milan, Italy 
66

Lunch Break

 
TUESDAY, JULY 11, 2000
11:00-12:30    HALL D
S63:  Session:
CARDIAC TRANSPLANTATION
Chairpersons: B. Heublein, Hannover, Germany 
B.M. Meiser, Munich, Germany
 
    Abstract Page
11:00  TGF-a1 AND PAI-1 GENE POLYMORPHISMS IN RELATION TO CORONARY ARTERY DISEASE BEFORE AND AFTER CLINICAL HEART TRANSPLANTATION
C.C. Baan, P.W.M. Hermans, C.T.J. Holweg, A.P.W.M. Maat, W. Weimar, A.H.M.M. Balk, Rotterdam, The Netherlands 
67
11:15  LEFT VENTRICULAR DYSFUNCTION DURING ACCELERATED TRANSPLANT CORONARY ARTERY DISEASE: RELATIVE IMPORTANCE OF DIFFUSE DISTAL VESSEL OBLITERATION
M. Dandel, E. Wellnhofer, J. Mueller, M. Hummel, R. Hetzer, Berlin, Germany 
67
11:30  FAILURE OF ACUTE IMPROVEMENT OF RIGHT VENTRICULAR FUNCTION DURING PROSTAGLANDIN E1 (PGE1) INFUSION PREDICTS SEVERE LV-DYSFUNCTION PATIENTS FOR URGENT TRANSPLANTATION
M. Hulsmann, T. Stefenelli, R. Berger, B. Sturm, A. Zukermann, W. Woloszczuk, R. Pacher, Vienna, Austria
 67
11:45  HEART TRANSPLANT OUTCOME IS WORSE USING GENDER MISMATCHED GRAFTS: AN RISK FACTOR ANALYSIS OF 640 CARDIAC TRANSPLANTS
B. Schlechta, A.A. Kocher, Y. Kaneko, M. Ploner, F. Nourani, M. Grimm, E. Wolner, G. Laufer, Vienna, Austria 
67
12:00  REGIONAL PERFUSION OF THE PORCINE MYOCARDIUM BEFORE AND AFTER ORTHOTOPIC HEART TRANSPLANTATION
P. Sommer, M. Siepe, J. Hilberath, J. Martin, K. Sarai, C. Ihling, F. Beyersdorf, Freiburg, Germany
 68
12:15  ATORVASTATIN THERAPY FOR HYPERLIPIDEMIA AFTER ORTHOTOPIC CARDIAC TRANSPLANTATION
G. Bhat, J. Brohm, L. Muncy, K. Erbeck, G.R. Aronoff, Louisville KY, USA 
68
12:30 

Lunch Break

 
TUESDAY, JULY 11, 2000
08:30-13:00    POSTER AREA
P301:  Poster Session:
MOLECULAR BIOLOGY AND BIOCHEMICAL ASPECTS OF HEART FAILURE
 
Board No.    Abstract Page
COULD UTROPHIN RESCUE THE DYSTROPHIN-DEFICIENCY?
P. Melacini, M. Fanin, A. Barchitta, C. Angelini, G.A. Danieli, S. Dalla Volta, Padua, Italy
 68
THE MODULATION OF L-TYPE CARDIAC CA CHANNEL BY PROTEIN KINASE A AND A ANCHORING PROTEIN
T. Yamakawa, K. Kobayashi, M. Mori, Y. Fukuda, T. Furukawa, T. Teramoto, T. Sato, Tokyo, Japan 
68
LEPTIN SERUM LEVELS ARE NOT INCREASED IN CACHECTIC HEART FAILURE PATIENTS
K. Tsilias, G. Filippatos, K. Venetsanou, J. Koutras, D. Manolatos, E. Karambinos, D. Economou, A. Kranidis, N. Sfougaris, F. Kardaras, L. Anthopoulos, G. Baltopoulos, Athens, Greece
 69
EFFECTS OF LOW ALTITUDE ON OXYGEN FREE RADICALS ACTIVITY IN CHRONIC CONGESTIVE HEART FAILURE PATIENTS
E. Goldhammer, S. Shnitzer, N. Kleiman, A. Lanir, E.G. Abinader, Haifa, Israel 
69
DIFFERENCES IN SARCOPLASMIC RETICULUM GENE EXPRESSION IN DIASTOLIC HEART FAILURE IN RABBIT
Y. Zhang, M. Zhong, W. Zhang, Z. Geng, G. Zhang, J. Zhao, X. Ji, Jinan, China
 69
THE ULTRASTRUCTURAL BASIS OF HEART FAILURE IN EXPERIMENTAL ATHEROSCLEROSIS
N.N. Kipshidze, N. Kakauridze, Z. Tsagareli, L. Gogiashvili, Tbilisi, Georgia
 69
TUESDAY, JULY 11, 2000
08:30-13:00    POSTER AREA
P302:  Poster Session:
ECHOCARDIOGRAPHY, DOPPLER MEASUREMENTS
 
Board No.    Abstract Page
ECHOCARDIOGRAPHIC DIAGNOSIS OF RUPTURED AND ANRUPTURED SINUS OF VALSALVA ANEURYSM: 10 YEARS EXPERIENCE
C. Ginghina, E. Apetrei, I. Stoian, M. Marinescu, D. Queshta, I. Kulcsar, F. Paraschiva, B. Fotiade, Bucharest, Romania
 70
8  CAN ATROPINE BE GIVEN IN EARLIER STAGES DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND THEREFORE SHORTEN THE TEST TIME PERIOD?
H.R. Villarrega, F. Rosso, P. Olaya, J. Sanchez, M. Badiel, Cali, Colombia 
70
EARLY DETECTION OF MYOCARDIAL ISCHEMIA DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY USING COLOR CODED TISSUE DOPPLER IMAGING
M. Harada, M. Nasu, A. Tashiro, S. Kuriki, K. Hiramori, Morioka, Japan 
70
10  STRESS ECHOCARDIOGRAPHY IN OCTOGENARIANS: SAFETY, TOLERABILITY AND BETTER VISUALIZATION OF THE MYOCARDIAL SEGMENTS USING NATIVE HARMONICS
H.R. Villarraga, P. Olaya, J. Sanchez, F. Rosso, M. Badiel, Cali, Colombia
 70
11  PROGNOSIS OF STRESS ECHOCARDIOGRAPHY IN OCTOGENARIANS WITH METHODS OF BETTER VISUALIZATION OF THE MYOCARDIAL SEGMENTS
H.R. Villarraga, A.J. Lores, P. Olaya, J. Sanchez, M. Badiel, F. Rosso, Cali, Colombia 
71
12  CAN ECHOCARDIOGRAPHY OFFER A COHERENT INTERPRETATION OF VARIOUS ENTITIES INCLUDED IN RESTRICTIVE CARDIOMYOPATHY?
C. Ginghina, E. Apetrei, I. Stoian, M. Marinescu, D. Qeshta, I. Kulcsar, V. Ene, D. Deleanu, L. Zarma, Bucharest, Romania
 71
  COMPARISON OF DIFFERENT ECHOCARDIOGRAPHIC PARAMETERS AND CLINICAL STATUS IN PATIENTS WITH DILATED CARDIOMYOPATHY
J.B. Dahm, E. Kuon, P.-N. Niederst, S. Raeth, Greifswald, Ebermannstadt, Hameln, Germany 
71
14  STRESS ECHOCARDIOGRAPHY: WHICH OF THE CORONARY REGIONS ARE ENHANCED BY NATIVE HARMONICS DURING REST AND PEAK IMAGE ACQUISITION IN BOTH PHARMACOLOGICAL AND EXERCISE MODALITIES WHEN COMPARED TO FUNDAMENTAL IMAGING?
H.R. Villarraga, F. Rosso, J. Sanchez, P. Olaya, M. Badiel, Cali, Colombia 
71
15  THE EVALUATION OF CARDIAC FUNCTION DURING CARDIOPULMONARY BYPASS USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY
H. Kubota, A. Furuse, Y. Kotsuka, S. Umezu, S. Takamoto, Tokyo, Japan 
72
16  APPROXIMATION TO DIASTOLIC CORONARY FLOW VELOCITY FROM ILLEGIBLE RECORDING BY TRANSTHORACIC PULSED DOPPLER ECHOCARDIOGRAPHY
S. Kuriki, M. Nasu, A. Tashiro, M. Harada, K. Hiramori, Fukushima, Japan 
72
17 

EVALUATION OF THE OPTIMAL DOSE OF INTRACORONARY ADENOSINE 5'-TRIPHOSPHATE FOR THE MEASUREMENT OF CORONARY FLOW RESERVE
T. Furuta, H. Yokoi, S. Mori, S. Kakizawa, W. Fujiwara, A. Sugiura, O. Inami, T. Kondo, Y. Abo, Y. Watanabe, Nagoya, Japan 

72
TUESDAY, JULY 11, 2000
08:30-13:00    POSTER AREA
P302:  Poster Session:
ECHOCARDIOGRAPHY, DOPPLER MEASUREMENTS (cont'd)
 
Board No.    Abstract Page
18  THE RELATION BETWEEN ST SEGMENT ELEVATION SHAPE AND BOTH OF LOW DOSE DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND CLINICAL COURSE IN EARLY PERIOD OF ANTERIOR MYOCARDIAL INFARCTION
A. Karadede, A.V. Temamogullari, O. Aydinalp, M.S. Ulgen, S. Algan, K. Itumur, N. Toprak, Diyarbakir, Turkey 
72
19  USE OF NEW ECHOCARDIOGRAPHIC PARAMETERS IN THE EVALUATION OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
S. Bayata, A. Pinar, U.A. Turk, I. Susam, M.H. Dinckal, N. Postaci, M. Yesil, Izmir, Turkey 
73
20  INCIDENCE OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IDENTIFIED BY ECHOCARDIOGRAPHY DURING EVALUATION OF UNEXPLAINED HYPOTENSION IN CONSECUTIVE PATIENTS
S. Verma, O.U. Rehman, G.A. Mensah, J.R. Gossage, V.B. Shah, Augusta GA, USA 
73
TUESDAY, JULY 11, 2000
08:30-13:00    POSTER AREA
P303:  Poster Session:
HEART FAILURE IN VALVULAR HEART DISEASE
 
Board No.    Abstract Page
21  MITRAL VALVE REPLACEMENT OR REPAIR WITH OR WITHOUT MAZE PROCEDURE-FOLLOW UP STUDY
R. Bachowski, T. Mandecki, S. Wo, M. Skowerski, M. Matuszewski, W. Domaradzki, Katowice, Poland 
73
22  EFFECTS OF EXERCISE ON TRANSMITRAL GRADIENT AND PULMONARY ARTERY PRESSURE IN PATIENTS WITH MITRAL STENOSIS AND ATRIAL FIBRILLATION
M. Kabukcu, F. Demircioglu, I. Ates, E. Yanik, E. Arslantas, A. Belgi, O. Sancaktar, O. Beyazit, F. Ersel, Antalya, Turkey
 73
23  EFFECTS OF CARDIOVERSION AND PERSISTENT SINUS RHYTHM ON LEFT VENTRICULAR GEOMETRY AND LEFT ATRIAL DIAMETER IN PATIENTS WITH MITRAL STENOSIS AND ATRIAL FIBRILLATION
M. Kabukcu, F. Demircioglu, I. Ates, E. Yanik, E. Arslantas, A. Belgi, O. Sancaktar, O. Beyazit, F. Ersel, Antalya, Turkey 
74
24 

THE ROLES OF AORTIC VALVE THICKENING AND SUBVALVULAR STENOSIS IN THE ETIOLOGY OF AORTIC VALVE REGURGITATION
H. Matsuoka, Nagasaki, Japan 

74
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P303:  Poster Session:
HEART FAILURE IN VALVULAR HEART DISEASE (cont'd)
Board No.    Abstract Page
25  SHOULD SYMPTOMS GUIDE SURGERY IN PATIENTS WITH SEVERE CHRONIC AORTIC REGURGITATION?
F. Tarasoutchi, M. Grinberg, P. Pomerantzeff, L.F. Cardoso, G.S. Spina, W.S. Avila, E.G. Rossi, P.L. da Luz, Sao Paulo, Brazil 
74
26  THE VALUE OF TEE IN PLANING AORTIC VALVE REPAIR OR REPLACEMENT IN PTS OPERATED ON TYPE A AORTIC DISSECTION WITH AORTIC REGURGITATION - 10 YEARS ECHOCARDIOGRAPHIC STUDY
M. Maciejewski, K. Piestrzeniewicz, M. Zielinska, P. Dejak, W. Koniarek, J.K. Wranicz, R. Jaszewski, J. Zaslonka, H. Bolinska, Lodz, Poland 
74
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P304: 

Poster Session:
PROGNOSTIC ASPECTS OF HEART FAILURE

 
Board No.    Abstract Page
27  CARDIAC LATE POTENTIALS AMONG HEART FAILURE PATIENTS
B. Bart, V. Larin, V. Larina, E. Krasnokutskaya, Moscow, Russia 
75
28  MORTALITY OF CONGESTIVE HEART FAILURE PATIENTS IN HOSPITAL INCREASES DURING INFLUENZA-PREVALENT PERIODS
M. Narukawa, K.K. Minezaki, H. Komatu, M. Nakamura, M. Naitoh, S. Hagiwara, Y. Shigeta, M. Okubo, Tochigi, Japan
 75
29  PROGNOSTIC VALUE OF LEFT VENTRICULAR POSTINFARCTION REMODELING IN DEVELOPMENT OF CHF
Y. Martinov, A. Vasyuk, A. Hadzegova, P. Krikunov, M. Kopeleva, E. Louchtchouk, K. Sologub, Moscow, Russia 
75
30  PROGNOSTIC VALUE OF ATRIAL FIBRILLATION IN THE PATIENTS WITH RESIDUAL ISCHEMIA
M. Dolzhenko, V. Bobrov, A. Kostyrya, S. Bilets'ky, Kiev, Ukraine 
75
31  NITRATE USE DOES NOT IMPROVE CLINICAL OUTCOMES FOLLOWING HOSPITALIZATION FOR HEART FAILURE
E.F. Philbin, T.A. Rocco Jr., P.L. Jenkins, Detroit MI, Rochester NY, USA 
76
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P305:  Poster Session:
EXERCISE PHYSIOLOGY AND REHABILITATION IN HEART FAILURE
 
Board No.    Abstract Page
32  CARDIAC REHABILITATION WITHOUT ENTRY EXERCISE TESTS IS SAFE AS WELL AS OUTCOME EFFECTIVE AND COST EFFECTIVE
T.R. McConnell, C.A. Laubach Jr., F.J. Menapace, Danville PA, USA
 76
33  REHABILITATION OF CONGESTIVE HEART FAILURE: IMPACT OF THE ETIOLOGY
D. Curnier, M. Galinier, A. Pathak, J. Fourcade, M. Bousquet, J.-M. Fauvel, J.-M. Senard, J.-L. Montastruc, Toulouse, St. Orens, France
 76
34  INDIVIDUAL DISPERSION OF EXERCISE TRAINING INTENSITY IN CONGESTIVE HEART FAILURE: RELATION WITH THE VENTILATORY THRESHOLD
D. Curnier, M. Galinier, A. Pathak, J. Fourcade, M. Bousquet, J.-M. Fauvel, J.-M. Senard, J.-P. Bounhoure, J.-L. Montastruc, Toulouse, St. Orens, France 
76
35  NON INVASIVE CARDIAC OUTPUT ESTIMATION DURING CARDIOPULMONARY EXERCISE TEST
S.M. Romano, F. Mazzuoli, M. Chiostri, M. Ciaccheri, G. Castelli, G. Camiciottoli, Florence, Italy 
77
36  PROLONGED BENEFICIAL EFFECTS OF CAPOZIDE ON EXERCISE TOLERANCE AMONG CHRONIC HEART FAILURE PATIENTS
B. Bart, V. Larina, Moscow, Russia
 77
37  SKELETAL MUSCLE MASS IS AN INDEPENDENT PREDICTOR OF EXERCISE CAPACITY IN CHRONIC HEART FAILURE
M. Cicoira, L. Zanolla, L. Franceschini, A. Rossi, G. Golia, P. Zeni, Verona, Italy 
77
TUESDAY, JULY 11, 2000
08:30 - 13:00    POSTER AREA
P306: 

Poster Session:
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY I

 
Board No.    Abstract Page
38  REVERSIBLE BLOCK AS A METHOD FOR LOCATION OF ATRIAL FIBRILLATION SOURCE
P. Jakuska, R. Lekas, B. Olsson, R. Benetis, Kausan, Lithuania, Lund, Sweden
 77
39  COMBINED PHARMACOLOGICAL AND ABLATIVE THERAPY OF CLASS IC DRUG INDUCED ATRIAL FLUTTER IN PATIENTS WITH RESISTANT ATRIAL FIBRILLATION
A. Bonso, F. Giada, S. Themistoclakis, G. Gasparini, A. Corrado, A. Lo Presti, A. Raviele, Mestre-Venice, Italy 
78
40  CURATIVE TREATMENT OF CHRONIC ATRIAL FIBRILLATION IN PATIENTS WITH SIMULTANEOUS CARDIOSURGICAL DISEASE WITH INTRAOPERATIVE MICROWAVE ABLATION
S.M. Tugtekin, M. Knaut, S.G. Spitzer, L. Karoly, H. Boehme, H. Raziq, S. Schueler, Dresden, Germany
 78
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P306:  Poster Session:
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY I (cont'd)
 
Board No.    Abstract Page
41  BERBERINE THERAPY FOR ISCHEMIC HEART FAILURE WITH COMPLICATING VENTRICULAR EXTRASYSTOLES BY MONITORING PLASMA BERBERINE CONCENTRATION
Y. Li, X. Zeng, X. Zeng, Y. Huang, Y. Yi, Chengdu, China 
78
42  THE TREATMENT BY LOW-DOSE AMIODARONE AND CARVEDILOL IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND HEART FAILURE
G.-P. Jong, C.-Y. Chen, Taichung, Taiwan-R.O.C.
 78
43  THE RELATIONSHIP OF CARDIOVASCULAR COMPLAINTS WITH SIGNIFICANT CARDIAC ARRHYTHMIAS ON 24-HOLTER MONITORING IN THE YOUNG
R.E. Ramboyong, B. Matawaran, A.C.F. De Lara-Llarena, Manila, Philippines
 79
44 

THE PRESENCE OF VENTRICULAR LATE POTENTIALS IN EARLY STAGE OF MYOCARDIAL INFARCTION IN PATIENTS WITH SERIOUS VENTRICULAR ARRHYTHMIAS - RELATION TO THE SITE OF INFARCTION
A. Kaasik, T. Ristimae, U. Soopold, R. Teesalu, Tartu, Estonia 

79
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P307:  Poster Session:
PRACTICE GUIDELINES, COST CONTAINMENT
 
Board No.    Abstract Page
45  THE CANADIAN CHF CLINICS NETWORK: REFERRAL PRACTICES AND TREATMENT
A. Ignaszewski, J. Malcolm, O. Arnold, J.D. Parker, J. Howlett, S. Smith, W. Czarnecki, Vancouver BC, Canada
 79
46  IMPACT OF AN APPLIED CLINICAL PATHWAY ON PATIENTS ADMITTED WITH ACUTE CONGESTIVE HEART FAILURE TO A COMMUNITY CORONARY CARE UNIT
S. Lins, C. Draus, A. Walblay, Dearborn MI, USA
 79
47  COMPARISON OF OPTIMAL CARE FOR CONGESTIVE HEART FAILURE BETWEEN CARDIOLOGISTS AND INTERNISTS AT A CANADIAN UNIVERSITY TEACHING HOSPITAL
J.G. Howlett, J. Stanley, M. MacDonald, D.E. Johnstone, Halifax NS, Canada 
80
48  MANAGING CHF: AN EVIDENCE AND OUTCOMES-BASED PHARMACY-MANAGED CLINIC
K. Findley, D. Frohnapple, Gainsville FL, USA 
80
49  THE CHANGING PROFILE OF THE CONGESTIVE HEART FAILURE PATIENT: UTILITY OF COMMERCIAL CHF MANAGEMENT PROGRAMS
K.O. Akosah, A.M. Schaper, K. Briggs, S. Devine, R. Sundaram, La Crosse WI, USA 
80
50  HEART FAILURE: MONITORING AND TELEMANAGEMENT - PAST, PRESENT AND FUTURE
S. Jacob, M. Mathew, Philadelphia PA, USA
 80
TUESDAY, JULY 11, 2000
08:30 - 13:00     POSTER AREA
P308: 

Poster Session:
MISCELLANEOUS

 
Board No.    Abstract Page
51  SYMPATHETIC NERVE TRAFFIC AND LEFT VENTRICULAR MASS INDEX IN OBESE NORMOTENSIVE SUBJECTS AFTER BODY WEIGHT REDUCTION
I. Moyssakis, D. Drosos, G. Anastasiadis, T. Doduras, H. Kasparian, M. Kyriakidis, Athens, Greece 
81
52  PLATELET ACTIVATING FACTOR PLAYS A CRITICAL ROLE IN DYNAMIC CARDIAC FUNCTIONAL AND STRUCTURAL ALTERATIONS IN THE INITIAL PHASE OF ENDOTOXEMIA
M. Iwase, L. Wang, C.S. Hui, K. Kiyoyuki, K. Takagi, T. Hasegawa, A. Noda, T. Nishizawa, T. Nagasaka, M. Yokota, Nagoya, Japan 
81
53  AUDIT OF DIAGNOSTIC CARDIAC CATHETERISATION IN A DISTRICT GENERAL HOSPITAL
L.D.R. Smith, G. Spyer, J.W. Dean, Exeter, Devon, UK
 81
54  MYOCARDIAL INFARCTION IN VERY YOUNG (<30 YEARS) AND IN VERY ELDERLY PATIENTS (>70 YEARS)
M. Gencbay, K. Sonmez, R. Demirbag, M. Degertekin, F. Turan, Istanbul, Turkey
 81
55  THE SPIRONOLACTONE TEST
R. Lupescu, G. Lupescu Jr., E. Perciun, I. Epure, Tg. Jiu, Romania
 82
56  CHANGE IN MORTALITY RATES AND ITS EFFECT ON SURVIVAL TIME
G. Wendland, B. Hinzpeter, Koeln, Germany
 82
57

 MORPHOLOGY OF ENDOCARDIAL MONOPHASIC ACTION POTENTIAL RECORDED FROM HUMAN RIGHT AND LEFT ATRIA
A. Murnan, D.T. Connelly, Liverpool, UK

 82
58  IMPACT OF SHORT-TERM ASPIRIN ON HEART RATE VARIABILITY IN HEALTHY MIDDLE-AGED MALES
T. Ristimae, R. Teesalu, Tartu, Estonia 
82
TUESDAY, JULY 11, 2000
14:00-16:00    HALL A
PL08: 

Plenary Session:
VASCULAR BIOLOGY AND NEUROHORMONAL MECHANISMS: BASIC RESEARCH AND CLINICAL ASPECTS
Chairpersons: S. Dalla Volta, Padova, Italy 
J.T. Willerson, Houston TX, USA

 
    Abstract Page
14:00  GENE THERAPY FOR THE INJURED VASCULAR ENDOTHELIUM (Invited Lecture)
J.T. Willerson, Houston TX, USA 
83
14:15  THE ENDOTHELIAL DYSFUNCTION IN HEART FAILURE: THE BIOLOGICAL BASIS FOR TREATMENT (Invited Lecture)
S. Dalla Volta, D. Anzulovic-Mirosevic, M. Plebani, M. Zaninotto, S. Altinier, A. Capelletti, M. Mion, A. Rozga, Padua, Italy, Split, Croatia 
83
14:30  CHRONIC INHIBITION OF NO SYNTHESIS INDUCES INTIMAL REMODELING IN THE AORTA OF NORMOCHOLESTEROLEMIC RATS (Invited Lecture)
M.A. Rossi, Sao Paulo, Brazil
 83
14:45  ANTIOXIDANT GENES: NOVEL THERAPEUTIC TARGETS FOR NITRIC OXIDE DONORS AND ASPIRIN (Invited Lecture)
H. Schroeder, Halle, Germany
 83
15:00  ENDOTHELIN-1 MODULATION OF SYMPATHETIC NERVE ACTIVITY IN HEART FAILURE (Invited Lecture)
I.H. Zucker, P.I. McConnell, J.-L. Liu, R. Pliquett, E. Brewer, Omaha NE, USA
 84
15:15  THE ROLE OF ALDOSTERONE ANTAGONISM IN ADVANCED HEART FAILURE: THE RESULTS OF THE RANDOMIZED ALDACTONE EVALUATION STUDY (RALES) (Invited Lecture)
P.C. Deedwania, Fresno CA, USA
 84
15:30  GENETIC DELETION OF NATRIURETIC PEPTIDE RECEPTOR-A AND CARDIOVASCULAR DISEASE (Invited Lecture)
K.N. Pandey, New Orleans LA, USA
 84
16:00  Coffee Break  
TUESDAY, JULY 11, 2000
14:00-16:15    HALL B
S64:  Session:
ISSUES SURROUNDING SURGICAL REVASCULARIZATION, HEART VALVE SURGERY AND CARDIAC TRANSPLANTATION
Chairpersons: V. Klauss, Munich, Germany 
M.A. Silver, Oak Lawn IL, USA
    Abstract Page
14:00  INTERCELLULAR AND VASCULAR CELL ADHESION MOLECULE LEVELS IN ENDOSCOPIC AND OPEN SAPHENOUS VEIN HARVESTING FOR CORONARY ARTERY BYPASS SURGERY
S.J. Alrawi, M. Samee, F. Balaya, R. Raju, D. Shirazian, A.J. Acinapaura, J.N. Cunningham, New York NY, USA
 85
14:15  BEATING VS. NON-BEATING HEART CARDIOPULMONARY BYPASS SURGERY
T.G. Sharp, P. Vijay, J.W. Brown, Indiana IN, USA
 85
14:30  ANGIOPLASTY VERSUS BYPASS SURGERY FOR CORONARY ARTERY DISEASE IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION - A META-ANALYSIS OF THE LITERATURE
R. Maraj, G. Crespo, M.N. Kotler, Philadelphia PA, USA
 85
14:45  ARTERIAL OFF-PUMP REVASCULARIZATION IN CRITICALLY ILL PATIENTS
H.-G. Wollert, K. Ansorge, H. Grubitzsch, L. Eckel, Karlsburg, Germany
 85
15:00  PREDICTORS OF SEVERE INTIMAL DISEASE IN RADIAL ARTERIES FOR USE IN CORONARY ARTERY SURGERY
P. Ruengsakulrach, R. Sinclair, I. Gordon, B. Buxton, Heidelberg, Australia
 86
15:15 

LONGTERM USE OF PROSTAGLANDIN E1 IN ADVANCED HEART FAILURE
M. Huelsmann, B. Stanek, B. Sturm, A. Bojic, G. Locker, M. Grimm, G. Laufer, R. Pacher, Vienna, Austria

 86
15:30  LEFT VENTRICULAR DYSFUNCTION AND EXERCISE TOLERANCE IN NON-REJECTING HEART TRANSPLANT RECIPIENTS
M. Dandel, J. Mueller, M. Hummel, R. Ewert, R. Hetzer, Berlin, Germany
 86
15:45  PERCUTANEOUS TRANSLUMINAL LASER MYOCARDIAL REVASCULARIZATION COMBINED WITH PRESSURE ELEVATION IN THE MANAGEMENT OF UNSTABLE ANGINA PECTORIS
J.C. Han, Shen Zhen, China
 86
15:55  MITRAL VALVE REPAIR FOR MITRAL REGURGITATION IN BARLOW'S DISEASE USING THE DOUBLE ORIFICE TECHNIQUE
F. Maisano, O. Alfieri, Milan, Italy
 87
16:05  EARLY RESULTS OF EPICARDIAL RADIOFREQUENCY ABLATION OF CHRONIC ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY
S. Benussi, S. Nascimbene, C. Pappone, P. Stefano, O. Alfieri, Milan, Italy
 87
16:15  Coffee Break  
TUESDAY, JULY 11, 2000
14:00-16:00    HALL C
S65: 

Session:
ARRHYTHMIAS - MECHANISMS AND MANAGEMENT
Chairpersons: J. Ge, Shanghai, China
J.L. Merino, Madrid, Spain

 
    Abstract Page
14:00  DOFETILIDE REDUCES HOSPITALISATIONS IN PATIENTS WITH ATRIAL FIBRILLATION AND LEFT VENTRICULAR DYSFUNCTION, A DIAMOND SUBSTUDY
O.D. Pedersen, Hellerup, Denmark
 87
14:15  DIAGNOSIS, MANAGEMENT AND OUTCOME OF ATRIAL FLUTTER IN THE PERINATAL AGE GROUP: A CONTROVERSIAL ISSUE
L.A. Lisowski, P.M. Verheijen, P. Stoutenbeek, A.A. Benatar, D.J.G. Soyeur, J.I. Brenner, C.S. Kleinman, E.J. Meijboom, Utrecht, The Netherlands, Liege, Belgium, Baltimore MD, New Haven CT, USA
 87
14:30  CARDIOVERSION OF ATRIAL FIBRILLATION AFTER THE EXCLUSION OF ATRIAL THROMBI BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY: SUCCESS RATE AND EMBOLIC RISK IN 127 PATIENTS WITH AND WITHOUT HEART FAILURE
J. Wagner, R. Griebenow, L.I. Kraemer, G. Quinkler, B. Hoeltmann, Cologne, Germany
 88
14:45  PROGNOSTIC VALUE OF THE CHARACTERISTICS OF NON-SUSTAINED TACHYCARDIA IN PATIENTS WITH NON-ISCHEMIC HEART FAILURE
E. (H) Hatzinikolaou, I. Kaprinis, E. Reppas, E. Boudioukos, N. Kabouridis, G. Katsaris, Thessaloniki, Greece
 88
15:00  PROGNOSTIC VALUE OF LEFT VENTRICULAR SYSTOLIC ASYNCHRONY AND MALIGNANT VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH DILATED CARDIOMYOPATHY
M. Gessner, G. Blazek, C. Dornaus, W. Kainz, H. Nobis, M. Gruska, E. Kunschitz, G. Gaul, Vienna, Austria
 88
15:15  AICD IN HEART FAILURE: IMPACT WITH AGGRESSIVE MEDICAL THERAPY
K. Akosah, W. Brown, A. Schaper, K. Briggs, J. Lenarz, S. Devine, R. Sundaram, La Crosse WI, USA
 88
15:30  HEART RATE AND HEART RATE VARIABILITY - NON-INVASIVE PREDICTORS OF MORTALITY IN PATIENTS WITH POSTINFARCTION LEFT VENTRICULAR DYSFUNCTION TREATED ACCORDING TO CURRENT GUIDELINES
J. Ruta, P. Ptaszynski, J.K. Wranicz, M. Maciejewski, M. Rosiak, Lodz, Poland
 89
15:45  FOLLOWED 1,196 CHAGASIC PATIENTS WITH TOTAL AV BLOCK FOR 26 YEARS AFTER PACEMAKER IMPLANT
O.T. Greco, A. Cardinalli Neto, R.V. Ardito, A.M. Lorga, Sao Jose Rio Preto, Brazil
 89
16:00  Coffee Break  
TUESDAY, JULY 11, 2000
14:00-16:30 

 

HALL D
S66:  Session:
ACUTE MYOCARDIAL INFARCTION: BASIC RESEARCH AND CLINICAL ASPECTS
Chairpersons: B.I. Jugdutt, Edmonton Alberta, Canada 
A. Lahiri, Harrow Middlesex, UK
 
    Abstract Page
14:00  QUANTIFICATION OF LEFT VENTRICULAR SHAPE CHANGE USING THREE-DIMENSIONAL ECHOCARDIOGRAPHY
S. Wong, M. Hubka, J. McDonald, E. Bolson, F. Sheehan*, Seatle WA, USA 
89
14:15  CHRONICAL USE OF GROWTH HORMONE INCREASES THE ACTION POTENTIAL DURATION IN RATS WITH MYOCARDIAL INFARCTION
J.G. Mill, C.M. Leite, G.N. Nascimento, R.N. Suave, G. Povoa, Vitoria, Brazil
 89
14:30  EFFECT OF INTERCELLULAR ADHESION MOLECULE-1 ON MYOCARDIAL INFARCTION AND VENTRICULAR REMODELING IN THE MOUSE MODEL
B. Metzler, C. Schaber, J. Mair, F. Hintringer, O. Pachinger, Q. Xu, Innsbruck, Austria 
90
14:45  WOMEN ARE AT HIGHER RISK OF DEATH THAN MEN IN THE SHORT-TERM AFTER MYOCARDIAL INFARCTION (MI) BUT NOT IN THE LONG-TERM: RESULTS FROM GISSI DATABASES
M.G. Franzosi, L. Santoro, Milan, Italy
 90
15:00  NON-INVASIVE ASSESSMENT OF REPERFUSION FOLLOWING FIBRINOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION
I.B.A. Menown, J. Allen, J. Anderson, A.A.J. Adgey, Belfast, UK 
90
15:15  DOUBLE BOLUS OF 750000 I.U. OF STREPTOKINASE - A NEW THROMBOLYTIC REGIMEN, MORE EFFICIENT THAN THE STANDARD 1500000 I.U. IN 60 MINUTES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
G. Tatu-Chitoiu, C. Teodorescu, M. Guran, M.Dan, P. Capraru, A. Tatu-Chitoiu, A. Bumbu, O. Istratescu-Wolkowski, M. Dorobantu, Bucharest, Romania 
90 
15:30  INCIDENCE OF HAEMORRHAGIC STROKE IN FIBRINOLYTIC TREATED PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION. TIM STUDY: A SUBGROUP ANALYSIS
L. Lopez, J.M. Cruz, A. Cabades, A. Castro, D. Garcia, V. Lopez, L. Martin, J. Velasco, C. Navas, F. Torres, C. Kalmeller 
91
15:45  INFLUENCE OF THROMBOLYTIC THERAPY ON THE INCIDENCE OF LEFT VENTRICULAR THROMBI AFTER ACUTE ANTERIOR MYOCARDIAL INFARCTION: ROLE OF SUCCESSFUL REPERFUSION
M. Ileri, E. Yetkin, I. Tandogan, I. Hisar, F. Kosar, S. Korkmaz, S. Goksel, Ankara, Turkey 
91
16:00  PREDICTION OF FRAME COUNTS 90 MINUTES AFTER THROMBOLYSIS BY MYOCARDIAL PROTEIN LEVELS AT RPESENTATION
K. Ramanathan, J.K. French, S.O.M. Manda, J.T. Stewart, H.D. White, Auckland, New Zealand 
91
16:15  PREDICTORS OF LEFT VENTRICULAR THROMBUS FORMATION IN PATIENTS WITH ANTERIOR MYOCARDIAL INFARCTION: ROLE OF ACTIVATED PROTEIN C RESISTANCE
E. Yetkin, A.R. Erbay, M. Ileri, S. Ayaz, A. Yanik, G. Yetkin, I. Tandogan, S. Cehreli, S. Korkmaz, S. Goksel, Ankara, Turkey
 91
16:30  Coffee Break  
TUESDAY, JULY 11, 2000
16:15-18:30    HALL A
PL09:  Plenary Session:
NEW HORIZONS IN THE MANAGEMENT OF HEART FAILURE
Chairpersons: M.R. Johnson, Chicago IL, USA 
M.J. Sole, Toronto ON, Canada
    Abstract Page
16:15  NEW THERAPIES FOR CONGESTIVE FAILURE IN CHILDREN (Invited Lecture)
R.D. Ross, Detroit MI, USA 
92
16:30  NEW STRATEGIES FOR THE THERAPY OF INFLAMMATORY CARDIOMYOPATHY ON THE BASIS OF HISTOLOGICAL, IMMUNOHISTOLOGICAL AND VIROLOGICAL ANALYSIS OF MYOCARDIAL BIOPSIES (Invited Lecture)
H.-P. Schultheiss, Berlin, Germany
 92
16:45  THE CHANGING CHALLENGES OF TREATING CONGESTIVE HEART FAILURE AS WE ENTER THE 21ST CENTURY (Invited Lecture)
M.R. Johnson, Chicago IL, USA
 92
17:00 

THE FAILING MYOCARDIUM IS NUTRITIONALLY DEFICIENT (Invited Lecture)
M.J. Sole, M. Keith, A. Ball, R. Kurian, K.N. Jeejeebhoy, Toronto ON, Canada

 92
17:15  REFRACTORY HEART FAILURE (RHF): NEW CONCEPT OF MEDICAL MANAGEMENT AND RISK STRATIFICATION (Invited Lecture)
B. Stanek, Vienna, Austria
 93
17:30  CONTINUED TAILORED THERAPY FOR ADVANCED HEART FAILURE USING NON-INVASIVE IMPEDANCE CARDIOGRAPHY (Invited Lecture)
F.W. Smart, C. Young, M. Khalid, H.O. Ventura, New Orleans LA, USA 
93
17:45  WHAT HAVE WE LEARNED FROM THE NORDIL STUDY? NORDIL - NORDIC DILTIAZEM STUDY (Invited Lecture)
P. Lund-Johansen, Bergen, Norway
 93
18:00 HERBAL, MEGAVITAMIN AND NUTRITIONAL SUPPLEMENT (NATUROCEUTICAL) CONSUMPTION BY HEART FAILURE PATIENTS (Invited Lecture)
D.D. Hermann, J.J. Kuiper, R. Shabetai, D. Carethers, D.J. Shaw, B.H. Greenberg, San Diego CA, USA 
93
18:15   CARDIAC PATIENT MANAGEMENT GUIDED BY EXERCISE PARAMETERS (Invited Lecture)
Y. Charuzi, T.K. Nishibun, T.W. Lang, Los Angeles CA, USA
 94
TUESDAY, JULY 11, 2000
16:15-18:15    HALL B
S67:  Session:
MOLECULAR BIOLOGY AND BIOCHEMICAL ASPECTS OF HEART FAILURE
Chairpersons: R.N.A. Gasser, Graz, Austria 
P.K. Singal, Winnipeg MB, Canada
 
    Abstract Page
16:15  AT II ANTAGONISM INHIBITS THE ELABORATION OF CHEMOKINES WHICH CONTRIBUTE TO CELL PROLIFERATION AND PLAQUE FORMATION IN RESPONSE TO INJURY FROM OX-LDL (Invited Lecture)
A. Simonini, B. Pitt, M. Aviram, R.M. Strieter, Los Angeles, CA, USA
 94
16:30  TROPONIN I ELEVATION DETERMINES THE PROGNOSIS OF ACUTE PULMONARY EMBOLISM
F. Post, T. Voigtlaender, D. Mertens, D. Peetz, B. Nowak, Mainz, Germany
 94
16:45  ENHANCED ADP-RIBOSYLATION AND THE POSSIBILITIES OF PROTECTION IN MYOCARDIAL DAMAGE CAUSED BY REACTIVE OXYGEN SPECIES
T. Habon, E. Szabados, K. Toth, B. Sumegi, Pecs, Hungary
 94
17:00  INSERTION/DELETION POLYMORPHISM IN THE ANGIOTENSIN CONVERTING ENZYME GENE AFFECTS HEART WEIGHT
K.-I. Nakahara, M. Nishinaga, S. Matsushita, Itabashi-Ku, Japan
 95
17:15  HEART TRANSPLANTATION IN PATIENTS WITH INHERITED MYOPATHIES ASSOCIATED WITH END-STAGE CARDIOMYOPATHY: MOLECULAR AND BIOCHEMICAL DEFECTS ON CARDIAC AND SKELETAL MUSCLE
P. Melacini, A. Gambino, A. Caforio, A. Barchitta, M.L. Valente, A. Angelini, M. Fanin, G. Thiene, C. Angelini, G. Casarotto, G.A. Danieli, S. Dalla Volta, Padua, Italy 
95
17:30 <